Home

Schuler Education Foundation

CIK 1512977 · last filed 2023-05-26

Schuler Education Foundation is a corporate insider who has filed 10 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing, for BIOL, was dated May 26, 2023. Across all open-market trades the lifetime net is +$17.3M, making them a net buyer over the disclosed history. The firm reports its address in Lake Forest, IL.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

10

Lifetime Open-Market Net

$17.33M

Filer Profile

Reported Address
100 N. FIELD DRIVE
SUITE 360
LAKE FOREST, IL 60045
Phone
(847) 607-2066
State of Incorporation
IL
Formerly Known As
Schuler Family Foundation (2011–2016)
Related Filers
Jack W. Schuler Living Trust — 1 joint filings, latest 2016-08-01
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIOLASE, INC (BIOL) Delisted 10%+ Owner 90,888 $0.02 $1.6K -$3.34M 1 2023-05-26
YIELD10 BIOSCIENCE, INC. (MBLX) Delisted 10%+ Owner 9,784,143 — — $5.53M 2 2015-06-23
HANSEN MEDICAL INC (HNSN) Delisted 10%+ Owner 2,361,225 — — $15.00M 4 2015-05-15
Transition Therapeutics Inc. (TTHI) Delisted 10%+ Owner 2,392,894 — — $139.7K 3 2011-03-18

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-05-26 BIOLASE, INC (BIOL) Delisted Mixed −4,106,290 -$1.84M EDGAR
2015-06-23 YIELD10 BIOSCIENCE, INC. (MBLX) Delisted Buy (P) +1,664,840 $5.53M EDGAR
2015-05-15 HANSEN MEDICAL INC (HNSN) Delisted Buy (P) +23,612,250 $0 EDGAR
2015-03-11 HANSEN MEDICAL INC (HNSN) Delisted Mixed +23,077 $15.00M EDGAR
2014-11-03 YIELD10 BIOSCIENCE, INC. (MBLX) Delisted Conv (C) +23,400,000 $0 EDGAR
2014-08-27 HANSEN MEDICAL INC (HNSN) Delisted Exer (X) +7,488,188 $8.46M EDGAR
2014-08-01 HANSEN MEDICAL INC (HNSN) Delisted Mixed — $0 EDGAR
2011-03-18 Transition Therapeutics Inc. (TTHI) Delisted Buy (P) +30,000 $60.9K EDGAR
2011-02-15 Transition Therapeutics Inc. (TTHI) Delisted Buy (P) +8,700 $17.9K EDGAR
2011-02-15 Transition Therapeutics Inc. (TTHI) Delisted Buy (P) +30,000 $60.9K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.